These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37595489)

  • 61. Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04.
    Chin M; Yokoyama R; Sumi M; Okita H; Kawai A; Hosono A; Koga Y; Sano H; Watanabe H; Ozaki T; Mugishima H;
    Pediatr Blood Cancer; 2020 May; 67(5):e28194. PubMed ID: 32077253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India.
    Sasi A; Chitikela S; Ganguly S; Biswas B; Pushpam D; Kumar A; Khan SA; Kumar VS; Kale SS; Biswas A; Barwad A; Mridha AR; Thulkar S; Bakhshi S
    Pediatr Hematol Oncol; 2024 Apr; 41(3):211-223. PubMed ID: 38189167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ewing sarcoma outcomes in a country with limited resources: Egypt as an example.
    Morsy AM; Abdel-Hadi S; Rezk KM; Amira G; Ahmed BM; Hussien MT; Ameen MG; Kamel HEM; Fouad DM; Attia AM; Salah A; Abd Elbadee OM; Yousseif AA; Abdelgawad MI; Fathy AH; Elwany YN; Ramadan IK; Mosallam KH; Abd Elwahab AI; Mahmoud KH; Amine MAF; Abd Elzaher AR; Eltyb HA; Hefni AM
    Am J Cancer Res; 2021; 11(6):3212-3226. PubMed ID: 34249456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the effects of local treatment strategies in non-metastatic Ewing sarcoma of bone.
    Zhang WT; Zhang WW; He ZY; Sun JY; Zhang L; Xia Q; Wu SG
    Expert Rev Anticancer Ther; 2018 May; 18(5):501-506. PubMed ID: 29537323
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term follow-up results of pediatric and adolescent patients with localized Ewing sarcoma treated based on stratified modalities.
    Zeng C; Chen T; Wang J; Sun F; Huang J; Lu S; Zhu J; Zhang Y; Sun X; Zhen Z
    Cancer Med; 2023 Apr; 12(8):9409-9419. PubMed ID: 36808251
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review.
    Haveman LM; Ranft A; Berg HVD; Klco-Brosius S; Ladenstein R; Paulussen M; Juergens H; Dirksen U; Merks JHM
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.
    Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Primary cutaneous and subcutaneous Ewing sarcoma.
    Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
    Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
    Issels RD; Lindner LH; Verweij J; Wust P; Reichardt P; Schem BC; Abdel-Rahman S; Daugaard S; Salat C; Wendtner CM; Vujaskovic Z; Wessalowski R; Jauch KW; Dürr HR; Ploner F; Baur-Melnyk A; Mansmann U; Hiddemann W; Blay JY; Hohenberger P; ;
    Lancet Oncol; 2010 Jun; 11(6):561-70. PubMed ID: 20434400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
    Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
    J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
    Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
    van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
    Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
    Seitz G; Urla C; Sparber-Sauer M; Schuck A; Vokuhl C; Blank B; Klingebiel T; Kazanowska B; Fuchs J; Koscielniak E
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27537. PubMed ID: 30421578
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multimodal Treatment in Pelvic Ewing Sarcoma: A Prognostic Factor Analysis.
    Muratori F; Totti F; Cuomo P; Beltrami G; Matera D; Tamburrini A; Capanna R; Roselli G; Campanacci DA
    Surg Technol Int; 2019 May; 34():489-496. PubMed ID: 30888673
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy.
    de Groot S; Gelderblom H; Fiocco M; Bovée JV; van der Hoeven JJ; Pijl H; Kroep JR
    Onco Targets Ther; 2017; 10():2963-2970. PubMed ID: 28652778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ewing and osteogenic sarcoma: evidence for multidisciplinary management.
    Sciubba DM; Okuno SH; Dekutoski MB; Gokaslan ZL
    Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S58-68. PubMed ID: 19829278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis.
    Uezono H; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Bradfield SM; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):974-981. PubMed ID: 32437922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
    Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
    Ferrari S; Sundby Hall K; Luksch R; Tienghi A; Wiebe T; Fagioli F; Alvegard TA; Brach Del Prever A; Tamburini A; Alberghini M; Gandola L; Mercuri M; Capanna R; Mapelli S; Prete A; Carli M; Picci P; Barbieri E; Bacci G; Smeland S
    Ann Oncol; 2011 May; 22(5):1221-1227. PubMed ID: 21059639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.